1. Home
  2. VZLA vs HRMY Comparison

VZLA vs HRMY Comparison

Compare VZLA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VZLA

Vizsla Silver Corp.

HOLD

Current Price

$3.87

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.59

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VZLA
HRMY
Founded
2017
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VZLA
HRMY
Price
$3.87
$36.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$7.00
$49.75
AVG Volume (30 Days)
13.5M
595.8K
Earning Date
12-12-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
N/A
$825,944,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
N/A
$16.28
P/E Ratio
N/A
$11.97
Revenue Growth
N/A
21.13
52 Week Low
$1.69
$25.52
52 Week High
$7.19
$40.87

Technical Indicators

Market Signals
Indicator
VZLA
HRMY
Relative Strength Index (RSI) 31.33 47.62
Support Level $3.58 $36.17
Resistance Level $5.47 $38.21
Average True Range (ATR) 0.46 1.29
MACD -0.25 0.01
Stochastic Oscillator 8.17 27.30

Price Performance

Historical Comparison
VZLA
HRMY

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: